Merck & Co., Inc. (MRK) vs NVIDIA Corporation (NVDA)
A side-by-side comparison of Merck & Co., Inc. and NVIDIA Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 11, 2026. Differences are shown without an overall score or investment verdict.
Different business models: MRK is classified in Healthcare; NVDA is classified in Technology. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
MRK
Merck & Co., Inc.
$143.94HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
NVDA
NVIDIA Corporation
$218.29TechnologyDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — MRK vs NVDA
growth of $100 · dividends reinvested · last 10yMRK +226.1% (+12.5%/yr)NVDA +14538.6% (+64.6%/yr)NVDA compounded faster over this window
Log scale — wide-divergence pair
MRK NVDA
MRK vs NVDA: by the numbers
- •NVDA is the larger company ($5.29T vs $355.49B market cap).
- •NVDA trades at the lower trailing earnings multiple (27.60 vs 115.15 P/E), one valuation lens rather than an overall verdict.
- •NVDA converts more revenue to profit (63.66% vs 4.78% net margin).
- •NVDA grew revenue faster over the past five years (69.34% vs 7.87% CAGR).
- •MRK pays the higher dividend yield (2.32% vs 0.13%).
Metrics side by side
Valuation
| Metric | MRK | NVDA |
|---|---|---|
| P/E ratio | 115.15 | 27.60 |
| Forward P/E | 52.41 | 23.59 |
| P/S ratio | 5.35 | 17.45 |
| P/B ratio | 8.48 | 23.09 |
| EV / EBITDA | 22.76 | 26.35 |
| FCF yield | 4.52% | 2.40% |
Profitability
| Metric | MRK | NVDA |
|---|---|---|
| Gross margin | 75.38% | 74.67% |
| Operating margin | 36.17% | 65.21% |
| Net margin | 4.78% | 63.66% |
| ROE | 7.57% | 84.23% |
| ROIC | 5.80% | 59.61% |
Dividends
| Metric | MRK | NVDA |
|---|---|---|
| Dividend yield | 2.32% | 0.13% |
| Payout ratio | 268.80% | 3.54% |
Growth (annualized)
| Metric | MRK | NVDA |
|---|---|---|
| Revenue CAGR (5Y) | 7.87% | 69.34% |
| EPS CAGR (5Y) | 21.21% | 94.31% |
| FCF CAGR (5Y) | 23.61% | 82.12% |
| Total return CAGR (5Y) | 18.15% | 57.72% |
Frequently asked
- Which has the lower trailing P/E, MRK or NVDA?
- NVDA has the lower trailing P/E: MRK trades at 115.15 and NVDA at 27.60. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, MRK or NVDA?
- Over the past five years, NVDA grew revenue faster — MRK at a 7.87% CAGR versus NVDA at 69.34%.
- Does MRK or NVDA pay a bigger dividend?
- MRK yields 2.32% and NVDA yields 0.13% based on trailing dividends and the latest price.
- Is MRK or NVDA more profitable?
- NVDA runs the higher net margin — MRK at 4.78% versus NVDA at 63.66%.
- How have MRK and NVDA total returns compared?
- Over the past 10 years, MRK delivered 12.68% and NVDA delivered 64.96% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Merck P/E ratioNVIDIA P/E ratioMerck dividend yieldNVIDIA dividend yieldMerck ROENVIDIA ROEMerck operating marginNVIDIA operating marginMerck revenue growthNVIDIA revenue growthMerck free cash flowNVIDIA free cash flow
Merck & NVIDIA appear in these rankings
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 11, 2026.